Family Speaks About Their Zofran Lawsuit Hoping To Help Others

The parents of a young boy are speaking out against GlaxoSmithKline and the drug Zofran.

February 26, 2016 /MM-prReach/ —

The parents of a young boy have chosen to speak publicly about their concerns regarding the drug Zofran. The mother has said the reason she took her case to the media is that, “I don’t want other mothers to go through what I’ve been through. And I don’t want them to feel guilty for the rest of their lives, like I do.”

Their complaint, which was filed October 27th, 2015 under case number 2:2015-cv-01897, alleges that their son was born with a congenital heart defect because the mother took the drug Zofran during her first trimester. He has required three life-saving heart surgeries as a result. They further allege that the manufacturer of Zofran, GlaxoSmithKline, unlawfully promoted the drug for “off-label” use.

This is just one of over 220 lawsuits that have been filed against GSK. In fact, the allegations in each case are so similar that the Judicial Panel on Multidistrict Litigation announced in October of 2015, that Zofran lawsuits would be consolidated into MDL 2657. The MDL was moved to the District of Massachusetts to be overseen by the honorable Judge F. Dennis Saylor. The plaintiffs and the defendant were all happy about this decision, hoping that it will save all parties time and money.

Parents are filing these lawsuits in the hope that they will be able to obtain compensation for their children’s medical expenses and pain and suffering. They believe that the drug has caused children to suffer from conditions such as atrial septal defect, ventricular septal defect, transposition of the greater vessels, respiratory distress syndrome, clubfoot, cleft lip, and cleft palate.

Zofran, which was approved by the FDA as a treatment for nausea and vomiting in patients undergoing chemotherapy, radiation, and anesthesia, is still on the market today and doctors continue to prescribe it to their patients, despite the growing litigation and the concerns raised by parents across the country.

Contact Info:
Name: Michael Monheit
Email: Michael@Monheit.com
Phone: 877-620-8411
Organization: ZofranLegal.com

Source: http://www.prreach.com/pr/22602

Release ID: 105160